Tilray Brands, Inc. TLRY

Domino Effect and f German Legalization

[Ventura2020]

Germany's recent partial legalization of cannabis has shaken up the industry and moved marijuana stocks. Will it have a domino effect on other European countries? How easy it is for the cannabis companies to jump on this opportunity and establish their presence in the German cannabis market?

 To find out, we continue our conversation with industry experts such as Dr. Constantin von der Groeben, a managing director of Demecan – the only German vertically integrated medicinal cannabis company; Denise Faltischek, a chief strategy officer and Head of International of a Canadian cannabis giant Tilray Brands (NASDAQ:TLRY) (TSX:TLRY), Jrgen Bickel, co-founder and managing director of Canopy Growth's (NASDAQ:CGC) Germany-based vaporization company Storz & Bickel; and Adam Wilks, CEO of Carma HoldCo. – the global licensing company. 

https://www.benzinga.com/amp/content/37423469

[Ventura2020]

Huge Benefits For Medical Marijuana Patients, Opportunities For Innovation & Research – Industry Vets Weigh In On Germany's Cannabis Reform https://www.benzinga.com/amp/content/37423458

[DaveInCalgary]

Faltischek told Benzinga that "of particular importance to Tilray is the adoption of the new Medical Cannabis Act, MedCanG, which provides de-scheduling of cannabis as a narcotic, which we expect will significantly expand the medical cannabis market in Germany allowing for wider insurance coverage as well as enhanced accessibility to high-quality cannabis for medical patient."